BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 35997567)

  • 21. The application of a multidisciplinary approach in the diagnosis of Castleman disease and Castleman-like lymphadenopathies: A 20-year retrospective analysis of clinical and pathological features.
    Pelliccia S; Rogges E; Cardoni A; Lopez G; Conte E; Faccini AL; De Vito R; Girardi K; Bianchi A; Annibali O; Fratoni S; Remotti D; De Angelis G; Giordano C; Palumbo G; Scarpino S; Del Porto F; Bianchi MP; Di Gregorio F; Tafuri A; Di Napoli A
    Br J Haematol; 2024 Feb; 204(2):534-547. PubMed ID: 37953489
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Validated international definition of the thrombocytopenia, anasarca, fever, reticulin fibrosis, renal insufficiency, and organomegaly clinical subtype (TAFRO) of idiopathic multicentric Castleman disease.
    Nishimura Y; Fajgenbaum DC; Pierson SK; Iwaki N; Nishikori A; Kawano M; Nakamura N; Izutsu K; Takeuchi K; Nishimura MF; Maeda Y; Otsuka F; Yoshizaki K; Oksenhendler E; van Rhee F; Sato Y
    Am J Hematol; 2021 Oct; 96(10):1241-1252. PubMed ID: 34265103
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunoglobulin G4-related disease and idiopathic multicentric Castleman's disease: confusable immune-mediated disorders.
    Sasaki T; Akiyama M; Kaneko Y; Takeuchi T
    Rheumatology (Oxford); 2022 Feb; 61(2):490-501. PubMed ID: 34363463
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The potential role of follicular helper T cells in idiopathic multicentric Castleman disease with and without TAFRO syndrome.
    Kurose N; Guo X; Shioya A; Mizutani KI; Kumagai M; Fujimoto S; Kawabata H; Masaki Y; Takai K; Aoki S; Nakamura S; Yamada S
    Pathol Res Pract; 2019 Oct; 215(10):152563. PubMed ID: 31358479
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mediterranean fever gene variants modify clinical phenotypes of idiopathic multi-centric Castleman disease.
    Endo Y; Koga T; Ubara Y; Sumiyoshi R; Furukawa K; Kawakami A
    Clin Exp Immunol; 2021 Oct; 206(1):91-98. PubMed ID: 34096620
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cutaneous Plasmacytosis and Idiopathic Multicentric Castleman Disease: A Spectrum of Disease?
    Drissi M; Dunlap R; Clayton L; Raess PW; Mengden Koon S; White K
    Am J Dermatopathol; 2022 Apr; 44(4):294-296. PubMed ID: 34966045
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Not Available].
    Bertinchamp R; Terriou L
    Rev Med Interne; 2022 Dec; 43(10S1):10S4-10S9. PubMed ID: 36657941
    [TBL] [Abstract][Full Text] [Related]  

  • 28. ADA2 Deficiency Mimicking Idiopathic Multicentric Castleman Disease.
    Van Nieuwenhove E; Humblet-Baron S; Van Eyck L; De Somer L; Dooley J; Tousseyn T; Hershfield M; Liston A; Wouters C
    Pediatrics; 2018 Sep; 142(3):. PubMed ID: 30139808
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Concordance between transbronchial lung cryobiopsy and surgical lung biopsy in patients with idiopathic multicentric Castleman disease: A report of four cases.
    Otoshi R; Kitamura H; Baba T; Muraoka T; Sekine A; Takemura T; Okudela K; Sawazumi T; Ogura T
    Respir Investig; 2024 Jan; 62(1):1-8. PubMed ID: 37925882
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An extranodal histopathological analysis of idiopathic multicentric Castleman disease with and without TAFRO syndrome.
    Kurose N; Mizutani KI; Kumagai M; Shioya A; Guo X; Nakada S; Fujimoto S; Kawabata H; Masaki Y; Takai K; Aoki S; Kojima M; Nakamura S; Kida M; Yamada S
    Pathol Res Pract; 2019 Mar; 215(3):410-413. PubMed ID: 30642741
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multicentric Castlemans disease. Symptoms, diagnostics and therapy.
    Adam Z; Řehák Z; Adamová Z; Koukalová R; Pour L; Krejčí M; Boichuk I; Sandecká V; Krejčí M; Štork M; Ševčíková S; Král Z
    Vnitr Lek; 2022; 68(1):41-53. PubMed ID: 35459346
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The lymph node transcriptome of unicentric and idiopathic multicentric Castleman disease.
    Horna P; King RL; Jevremovic D; Fajgenbaum DC; Dispenzieri A
    Haematologica; 2023 Jan; 108(1):207-218. PubMed ID: 35484648
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Idiopathic plasmacytic lymphadenopathy: A conceptual history along with a translation of the original Japanese article published in 1980.
    Takeuchi K
    J Clin Exp Hematop; 2022; 62(2):79-84. PubMed ID: 35768240
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hepatic Campylobacter jejuni infection in patients with Castleman-Kojima disease (idiopathic multicentric Castleman disease with thrombocytopenia, anasarca, fever, reticulin fibrosis, and organomegaly (TAFRO) syndrome).
    Kageyama C; Igawa T; Gion Y; Iwaki N; Tabata T; Tanaka T; Kondo E; Sakai H; Tsuneyama K; Nomoto K; Noguchi H; Yoshino T; Yokota K; Sato Y
    Pathol Int; 2019 Oct; 69(10):572-579. PubMed ID: 31631463
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Is TAFRO syndrome a subtype of idiopathic multicentric Castleman disease?
    Fujimoto S; Sakai T; Kawabata H; Kurose N; Yamada S; Takai K; Aoki S; Kuroda J; Ide M; Setoguchi K; Tsukamoto N; Iwao-Kawanami H; Kawanami T; Mizuta S; Fukushima T; Masaki Y
    Am J Hematol; 2019 Sep; 94(9):975-983. PubMed ID: 31222819
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Overview of Castleman disease.
    Dispenzieri A; Fajgenbaum DC
    Blood; 2020 Apr; 135(16):1353-1364. PubMed ID: 32106302
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Castleman disease and mimickers: Clinicopathological findings of atypical lymphoproliferative disorders associated with autoimmune disease.
    Nakazato Y; Tsuchida S; Takada-Owada A; Onozaki M; Noda S; Nozawa Y; Takaoka M; Ishida K
    J Clin Exp Hematop; 2022; 62(3):119-126. PubMed ID: 36171095
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Investigation of IgG4-positive cells in idiopathic multicentric Castleman disease and validation of the 2020 exclusion criteria for IgG4-related disease.
    Nishikori A; Nishimura MF; Nishimura Y; Notohara K; Satou A; Moriyama M; Nakamura S; Sato Y
    Pathol Int; 2022 Jan; 72(1):43-52. PubMed ID: 34762752
    [TBL] [Abstract][Full Text] [Related]  

  • 39. HHV-8-negative, idiopathic multicentric Castleman disease: novel insights into biology, pathogenesis, and therapy.
    Fajgenbaum DC; van Rhee F; Nabel CS
    Blood; 2014 May; 123(19):2924-33. PubMed ID: 24622327
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Virome capture sequencing does not identify active viral infection in unicentric and idiopathic multicentric Castleman disease.
    Nabel CS; Sameroff S; Shilling D; Alapat D; Ruth JR; Kawano M; Sato Y; Stone K; Spetalen S; Valdivieso F; Feldman MD; Chadburn A; Fosså A; van Rhee F; Lipkin WI; Fajgenbaum DC
    PLoS One; 2019; 14(6):e0218660. PubMed ID: 31242229
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.